OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients
Deborah Theiler, Marco Cattaneo, Lawrence Dierickx, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6290-6290
Open Access | Times Cited: 7
Deborah Theiler, Marco Cattaneo, Lawrence Dierickx, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6290-6290
Open Access | Times Cited: 7
Showing 7 citing articles:
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Martina Di Franco, Lucia Zanoni, Emilia Fortunati, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 538-550
Open Access | Times Cited: 8
Current perspectives on neuroendocrine tumors
Sunil Kumar Verma, R. P. Khare, Devendra Singh
hLife (2024) Vol. 2, Iss. 11, pp. 563-575
Open Access | Times Cited: 3
Sunil Kumar Verma, R. P. Khare, Devendra Singh
hLife (2024) Vol. 2, Iss. 11, pp. 563-575
Open Access | Times Cited: 3
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
Francesco Panzuto, Manuela Albertelli, Maria Luisa De Rimini, et al.
Journal of Endocrinological Investigation (2024) Vol. 48, Iss. 1, pp. 23-36
Open Access | Times Cited: 3
Francesco Panzuto, Manuela Albertelli, Maria Luisa De Rimini, et al.
Journal of Endocrinological Investigation (2024) Vol. 48, Iss. 1, pp. 23-36
Open Access | Times Cited: 3
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms
Marek Saracyn, Adam Daniel Durma, Barbara Bober, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 185-185
Open Access | Times Cited: 9
Marek Saracyn, Adam Daniel Durma, Barbara Bober, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 185-185
Open Access | Times Cited: 9
Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience
Vladimir Vukomanović, Katarina Vuleta Nedic, Marija Živković Radojević, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 1
Vladimir Vukomanović, Katarina Vuleta Nedic, Marija Živković Radojević, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 1
Neuroendocrine Tumors: Treatment and Management
Alessio Impériale
Cancers (2022) Vol. 14, Iss. 16, pp. 4048-4048
Open Access | Times Cited: 2
Alessio Impériale
Cancers (2022) Vol. 14, Iss. 16, pp. 4048-4048
Open Access | Times Cited: 2
Pharmacotherapeutic Management of Well-Differentiated Neuroendocrine Tumors in Older Patients: Current Status and Potential Therapies
Christiana Crook, Yahan Zhang, Daneng Li
Drugs & Aging (2022) Vol. 39, Iss. 4, pp. 257-269
Closed Access
Christiana Crook, Yahan Zhang, Daneng Li
Drugs & Aging (2022) Vol. 39, Iss. 4, pp. 257-269
Closed Access
